Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease

Objective To investigate whether subcortical grey matter atrophy predicts progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD), and to compare subcortical volumes between AD, MCI and controls. To assess the correlation between subcortical grey matter volumes and severity of cognitive impairment. Methods We included 773 participants with three-dimensional T1-weighted MRI at 3 T, made up of 181 controls, who had subjective memory symptoms with normal cognition, 201 MCIs and 391 AD. During follow-up (2.0±0.9 years), 35 MCIs converted to AD (progressive MCI) and 160 MCIs remained stable (stable MCI). We segmented volumes of six subcortical structures of the amygdala, thalamus, caudate nucleus, putamen, globus pallidus and nucleus accumbens, and of the hippocampus, using FMRIBs integrated registration and segmentation tool. Results Analysis of variances, adjusted for sex and age, showed that all structures, except the globus pallidus, were smaller in AD than in controls. In addition, the amygdala, thalamus, putamen, nucleus accumbens and hippocampus were smaller in MCIs than in controls. Across groups, all subcortical greymatter volumes, except the globus pallidus, showed a positive correlation with cognitive function, as measured by Mini Mental State Examination (MMSE) (0.16<r<0.28, all p<0.05). Cox proportional hazards analyses adjusted for age, sex, education, Cambridge Cognitive Examination-Revised (CAMCOG-R) and MMSE showed that smaller volumes of the hippocampus and nucleus accumbens were associated with increased risk of progression from MCI to AD (HR (95% CI) 1.60 (1.15 to 2.21); 1.60 (1.09 to 2.35), p<0.05). Conclusions In addition to the hippocampus, the nucleus accumbens volume loss was also associated with increased risk of progression from MCI to AD. Furthermore, volume loss of subcortical grey matter structures was associated with severity of cognitive impairment.

[1]  H. Braak,et al.  Alzheimer's disease affects limbic nuclei of the thalamus , 2004, Acta Neuropathologica.

[2]  Mark Jenkinson,et al.  Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis , 2012, NeuroImage.

[3]  M. A. Buchem,et al.  Ventral striatal volume is associated with cognitive decline in older people: a population based MR-study , 2012, Neurobiology of Aging.

[4]  J. Cummings,et al.  Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. , 2002, Journal of psychosomatic research.

[5]  Stephen M. Smith,et al.  A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.

[6]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[7]  Marina Boccardi,et al.  Striatal morphology in early-onset and late-onset Alzheimer's disease: a preliminary study , 2013, Neurobiology of Aging.

[8]  C. Salzman Camdex-R: The Cambridge Examination for Mental Disorders of the Elderly, Revised , 2000 .

[9]  Nick C Fox,et al.  Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers. , 2011, Brain : a journal of neurology.

[10]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[11]  I. Veer,et al.  Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study , 2008, Brain : a journal of neurology.

[12]  M. Summers,et al.  Exploring the validity of mild cognitive impairment (MCI) subtypes: Multiple-domain amnestic MCI is the only identifiable subtype at longitudinal follow-up , 2014, Journal of clinical and experimental neuropsychology.

[13]  Sebastien Ourselin,et al.  Cerebral atrophy in mild cognitive impairment and Alzheimer disease , 2013, Neurology.

[14]  M. Borga,et al.  Small baseline volume of left hippocampus is associated with subsequent conversion of MCI into dementia: The Göteborg MCI study , 2008, Journal of the Neurological Sciences.

[15]  A. Simmons,et al.  Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease , 2010, Neurobiology of Aging.

[16]  H. Braak,et al.  Alzheimer's Disease: Striatal Amyloid Deposits and Neurofibrillary Changes , 1990, Journal of neuropathology and experimental neurology.

[17]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[18]  Ronald Killiany,et al.  Structural Magnetic Resonance Imaging in Established and Prodromal Alzheimer Disease: A Review , 2003, Alzheimer disease and associated disorders.

[19]  C. Jack,et al.  Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment , 2008, Neurology.

[20]  Annalena Venneri,et al.  Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. , 2008, Brain : a journal of neurology.

[21]  Daniel Rueckert,et al.  An evaluation of four automatic methods of segmenting the subcortical structures in the brain , 2009, NeuroImage.

[22]  P. Thompson,et al.  Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[23]  L. Younes,et al.  Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: Detecting, quantifying, and predicting , 2014, Human brain mapping.

[24]  G. Zaccara,et al.  Behavioral and Psychological Symptoms in Alzheimer’s Disease: Frequency and Relationship with Duration and Severity of the Disease , 2005, Dementia and Geriatric Cognitive Disorders.

[25]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[26]  K. Heilman,et al.  The cortical neuroanatomy of neuropsychological deficits in mild cognitive impairment and Alzheimer's disease: A surface-based morphometric analysis , 2011, Neuropsychologia.

[27]  Dan Mungas,et al.  Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. , 2009, Archives of neurology.

[28]  Sang Won Seo,et al.  Volume reduction in subcortical regions according to severity of Alzheimer’s disease , 2011, Journal of Neurology.

[29]  R. Petersen Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[30]  Frederik Barkhof,et al.  Optimizing patient care and research: the Amsterdam Dementia Cohort. , 2014, Journal of Alzheimer's disease : JAD.

[31]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[32]  C. Jack,et al.  Mild cognitive impairment: ten years later. , 2009, Archives of neurology.

[33]  Dong Young Lee,et al.  Predictive validity and diagnostic stability of mild cognitive impairment subtypes , 2012, Alzheimer's & Dementia.

[34]  M. Roth CAMDEX : the Cambridge examination for mental disorders of the elderly , 1999 .

[35]  Li Shen,et al.  Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort , 2009, Current Alzheimer research.

[36]  Carlo Caltagirone,et al.  Combined volumetry and DTI in subcortical structures of mild cognitive impairment and Alzheimer's disease patients. , 2010, Journal of Alzheimer's disease : JAD.

[37]  Jakub Hort,et al.  Cortical and Subcortical Atrophy in Alzheimer Disease: Parallel Atrophy of Thalamus and Hippocampus , 2014, Alzheimer disease and associated disorders.

[38]  Cindee M. Madison,et al.  Comparing predictors of conversion and decline in mild cognitive impairment , 2010, Neurology.

[39]  Nick C Fox,et al.  Hippocampal atrophy rates in Alzheimer disease , 2009, Neurology.

[40]  Masanori Nakagawa,et al.  High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types. , 2009, Archives of neurology.

[41]  D. Mann,et al.  The topographic distribution of brain atrophy in Alzheimer's disease , 2004, Acta Neuropathologica.